DEMIURGE TECHNOLOGIES AG

Demiurge pioneers high-accuracy MoA-based prediction of clinical trial outcomes.
DEMIURGE TECHNOLOGIES AG
Social Links:
Industry:
Biotechnology Neuroscience
Founded:
2015-05-22
Address:
Zug, Zug, Switzerland
Country:
Switzerland
Website Url:
http://www.demiurge.technology
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
9.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Google GStatic Google Static Content
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Nimbus Therapeutics
Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company.
Current Employees Featured
Founder
Official Site Inspections
http://www.demiurge.technology Semrush global rank: 7.27 M Semrush visits lastest month: 110
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147

More informations about "Demiurge Technologies AG"
VALIDATION | DemiurgeTechnologies
Demiurge has achieved an 22-month-long public track record of 84% (103/123) accuracy in our prospective predictions of first-in-class phase 2 and phase 3 clinical trial results. as of 03 โฆSee details»
Demiurge Technologies AG - Crunchbase Company Profile
Contact Email [email protected]; Demiurge pioneers high-accuracy MoA-based prediction of clinical trial outcomes. Products and Services. Powered by AI . ... 9,904 Number โฆSee details»
Demiurge Technologies AG - LinkedIn
Demiurge Technologies AG | 803 followers on LinkedIn. Demiurge pioneers high-accuracy MoA-based prediction of clinical trial outcomes. | Demiurge pioneers high-accuracy MoA-based prediction of ...See details»
Demiurge Technologies 2025 Company Profile: โฆ
Is Demiurge Technologies a private or public company? Demiurge Technologies is a Private company. What is Demiurge Technologiesโs current revenue? The โฆSee details»
Demiurge Technologies AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Demiurge Technologies AG of Zug, ZUG. Get the latest business insights from Dun & Bradstreet.See details»
Demiurge Technologies - Products, Competitors, Financials, โฆ
Demiurge Technologies specializes in the prediction of clinical trial outcomes using virtual patient models within the life sciences domain. The company offers a platform that generates โฆSee details»
Demiurge Technologies AG - Org Chart, Teams, Culture & Jobs
View Demiurge Technologies AG's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
PLATFORM | DemiurgeTechnologies
Demiurge Technologies delivers high-accuracy AI-based predictions of clinical trial outcomes for all diseases and offers clinical-efficacy-prediction-based valuation of biopharma assets for all โฆSee details»
Demiurge Technologies - VentureRadar
By integrating neuroscience with deep learning in their shared domain of mobile agents that generalize all animals and robots, Demiurge is exclusively focused on translating the โฆSee details»
Company profile from Demiurge Technologies AG on jobs.ch
Company profile of Demiurge Technologies AG, Hofstrasse 1a in 6300 Zug. Hire now for freeSee details»
Demiurge Technologies AG - startup.ch
Demiurge Technologies AG: At Demiurge, we focus on the fastest convergence to the discovery of the universal blueprint of animal brains and the best design of mobile robots on earth and in โฆSee details»
Demiurge Technologies - Craft
Demiurge Technologies has 5 employees at their 1 location. See insights on Demiurge Technologies including office locations, competitors, revenue, financials, executives, โฆSee details»
Demiurge Technologies AG:Company Profile & Technical Research ...
Demiurge Technologies is a company that provides Neuroscience, Demiurge, Utility model and more. Demiurge Technologies is headquartered in Switzerland Zug. Demiurge Technologies โฆSee details»
Demiurge Technologies Company Profile: Funding, Investors
Demiurge Technologies Submit feedback Claim this profile Demiurge is a world-leading Swiss artificial intelligence, neuroscience, and pharmaceutical company with a focus on translating โฆSee details»
Demiurge Technologies Company Information - Funding, โฆ
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
Demiurge Technologies AG - Swiss Biotech
Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members, the association works to secure favorable framework โฆSee details»
Demiurge Technologies AG - Company Information - 6sense
Find useful insights on Demiurge Technologies AG's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Demiurge โฆSee details»
Demiurge Technologies - VentureRadar
" At Demiurge, we are redesigning the units of deep neural networks to solve the fundamental challenges of training data shortage and adversarial examples that are tethering all deep โฆSee details»
AI-BIOPHARMA | DemiurgeTechnologies
We apply the algorithmic insights of the next generation of neural networks to replacing the inefficient blind-men-and-an-elephant-style data-driven approach to drug discovery with an โฆSee details»
NEWSROOM - DemiurgeTechnologies
Apr 30, 2020 Demiurge AI Discovers PI3K inhibitors as a Novel Candidate Treatment Selective for 2019 Novel Coronavirus (COVID-19) SWITZERLAND, FRIDAY, FEBRUARY 14, 2020 โฆSee details»